Maharashtra Health Minister Rajesh Tope on Thursday said the state has sought additional stocks of Covaxin for providing precautionary or booster dose to co-morbid people aged above 60, health and frontline workers.
Tope, who participated in a virtual meeting with Prime Minister Narendra Modi on the prevailing COVID-19 situation in the country, later told reporters that the state has sought 40 lakh doses of Covaxin.
As per the Centre's guidelines, the home-grown vaccine manufactured by Bharat Biotech is the only one which is to be administered to teenagers in the 15 to 18 age group.
The minister said Maharashtra has also sought 50 lakh doses of Covishield for administering the precautionary dose. He said feedback from district authorities was that there was a shortage of Covaxin for the booster dose.
Tope said the Centre should take steps to tackle vaccine hesitancy among people. The minister said pharmacies have been asked to keep a record of people purchasing coronavirus home testing kits and provide information about the same to government authorities.
He said 4,000 swab samples have been taken for genomic sequencing so far in the state, out of which 1,300 were found infected with the Omicron variant and 2,700 with the Delta strain of coronavirus. Tope said the Centre should bring clarity in treatment protocol of coronavirus patients.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU